Publications

• Health-Related Quality of Life Outcomes With Two Different Starting Doses of Lenvatinib in Combination With Everolimus for Previously Treated Renal Cell Carcinoma , The Oncologist (2022)
• Health-related quality-of-life outcomes in patients with advanced renal cell carcinoma treated with lenvatinib plus pembrolizumab or everolimus versus sunitinib (CLEAR): a randomised, phase 3 study , The Lancet Oncology (2022)
• Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial , ˜The œLancet. Gastroenterology & hepatology (2021)
• Patients’ satisfaction with long-acting injectable somatostatin analog therapy for neuroendocrine tumors , Journal of Patient-Reported Outcomes (2021)
• Utilization and safety of onabotulinumtoxinA for the prophylactic treatment of chronic migraine from an observational study in Europe , Cephalalgia (2017)
• Health-related quality of life and disease symptoms in postmenopausal women with HR⁺, HER2⁻advanced breast cancer treated with everolimus plus exemestane versus exemestane monotherapy , Current Medical Research and Opinion (2013)
• Health‐related quality of life of patients with advanced breast cancer treated with everolimus plus exemestane versus placebo plus exemestane in the phase 3, randomized, controlled, BOLERO‐2 trial , Cancer (2013)
• Health-related quality of life in patients with metastatic colorectal cancer treated with panitumumab in first- or second-line treatment , British Journal of Cancer (2011)
• Health-related quality of life and colorectal cancer-specific symptoms in patients with chemotherapy-refractory metastatic disease treated with panitumumab , International Journal of Colorectal Disease (2010)
• Help-Seeking Behavior of Women with Self-Reported Distressing Sexual Problems , Journal of Women s Health (2009)

View all publications